Panbela Therapeutics, Inc.【PBLA】Cash flow
Market cap
$63.36K
P/E ratio
| 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
| Stock-based compensation | 600 | 600 | - | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Cash from operations | 37,113 | -35,390 | -11,453 | -4 | -2 | -3 | -2 | -3 | -4 | -7 | -15 | -25 |
| Capital expenditures | - | -5,115 | - | - | - | - | - | - | - | - | - | - |
| Cash from investing | 19,123 | -5,115 | 124,720 | 1 | - | - | - | - | - | -1 | -1 | 0 |
| Repayments of term debt | - | - | - | - | - | - | 0 | 0 | 0 | - | - | - |
| Cash from financing | 6,851 | -11,611 | -8,317 | 3 | 2 | 3 | 4 | 4 | 10 | 10 | 5 | 26 |
| Free cash flow | - | - | - | - | - | - | - | - | - | - | - | |
| FCF margin (%) | - | - | - | - | - | - | - | - | - | - | - |